R&D | April 22, 2026
New brain study reveals why alcohol relapse remains a persistent challenge
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Pharma giant targets new standards of care
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
By cutting pain crises & boosting haemoglobin
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
Subscribe To Our Newsletter & Stay Updated
